Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Cell Biophysics
|
January 1, 1993
Targeting of superantigens
T Kalland, M Dohlsten, L Abrahmsén, et al.
Neuropharmacology
|
May 3, 2002
Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue
L-P Zou, N Abbas, I Volkmann, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1993
Monoclonal antibodies and superantigens: a novel therapeutic approach
T Kalland, M Dohlsten, P Lind, et al.
International Immunology
|
September 1, 1995
A novel co-stimulatory T cell antigen co-expressed on renal cell carcinoma
T Labuda, P Lando, O Björkdahl, et al.
Cellular Immunology
|
October 1, 1991
Induction of interleukin-1 in human monocytes by the superantigen staphylococcal enterotoxin A requires the participation of T cells
A Gjörloff, H Fischer, G Hedlund, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 13, 1994
Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy
M Dohlsten, L Abrahmsén, P Björk, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1991
A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells
G Hedlund, M Dohlsten, T Herrmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1993
Monocyte-regulated IFN-gamma production in human T cells involves CD2 signaling
A G Wingren, K Dahlenborg, M Björklund, et al.
Cellular Immunology
|
May 1, 1996
Fusion of a signal sequence to the interleukin-1 beta gene directs the protein from cytoplasmic accumulation to extracellular release
A G Wingren, O Björkdahl, T Labuda, et al.
British Journal of Cancer
|
February 8, 2007
A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma
D M Shaw, N B Connolly, P M Patel, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Cell Biophysics
|
January 1, 1993
Targeting of superantigens
T Kalland, M Dohlsten, L Abrahmsén, et al.
Neuropharmacology
|
May 3, 2002
Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue
L-P Zou, N Abbas, I Volkmann, et al.
Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1993
Monoclonal antibodies and superantigens: a novel therapeutic approach
T Kalland, M Dohlsten, P Lind, et al.
International Immunology
|
September 1, 1995
A novel co-stimulatory T cell antigen co-expressed on renal cell carcinoma
T Labuda, P Lando, O Björkdahl, et al.
Cellular Immunology
|
October 1, 1991
Induction of interleukin-1 in human monocytes by the superantigen staphylococcal enterotoxin A requires the participation of T cells
A Gjörloff, H Fischer, G Hedlund, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 13, 1994
Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy
M Dohlsten, L Abrahmsén, P Björk, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 15, 1991
A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells
G Hedlund, M Dohlsten, T Herrmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1993
Monocyte-regulated IFN-gamma production in human T cells involves CD2 signaling
A G Wingren, K Dahlenborg, M Björklund, et al.
Cellular Immunology
|
May 1, 1996
Fusion of a signal sequence to the interleukin-1 beta gene directs the protein from cytoplasmic accumulation to extracellular release
A G Wingren, O Björkdahl, T Labuda, et al.
British Journal of Cancer
|
February 8, 2007
A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma
D M Shaw, N B Connolly, P M Patel, et al.
Page
of 12